Roger Jeffs has an estimated net worth of $344 Million. This is based on reported shares across multiple companies, which include UNITED THERAPEUTICS Corp, Liquidia Corp, Axsome Therapeutics, Inc., SANGAMO THERAPEUTICS, INC, ALBIREO PHARMA, INC., Axovant Sciences Ltd., and Dova Pharmaceuticals Inc..

2015 was Roger Jeffs's most active year for acquiring shares with 84 total transactions. Roger Jeffs's most active month to acquire stocks was the month of December. 2015 was Roger Jeffs's most active year for disposing of shares, totalling 158 transactions. Roger Jeffs's most active month to dispose stocks was the month of November. 2009 saw Roger Jeffs paying a total of $14,398,742.50 for 205,950 shares, this is the most they've acquired in one year. In 2014 Roger Jeffs cashed out on 1,211,352 shares for a total of $67,404,056.04, their largest year based on trade value.